Chemical Compound

ROLITETRACYCLINE

CAS Registry Number 751-97-3

Back to search Request a Quote

Primary Record

ROLITETRACYCLINE

In stock: 4,727 g
Purity: 98.2 %
CAS: 751-97-3

Compound Identifiers & Properties

CAS: 751-97-3
PubChem CID: 54682938
SMILES: C[C@@]1([C@H]2C[C@H]3[C@@H](C(=O)C(=C([C@]3(C(=O)C2=C(C4=C1C=CC=C4O)O)O)O)C(=O)NCN5CCCC5)N(C)C)O
Canonical SMILES: CN(C)[C@@H]1C(=O)C(C(=O)NCN2CCCC2)=C(O)[C@@]2(O)C(=O)C3=C(O)c4c(O)cccc4[C@@](C)(O)[C@H]3C[C@@H]12

Names & Synonyms

ROLITETRACYCLINE
Syntetrin
Reverin
Rolitetraciclina
Velacycline
Synterin
Rolitetracyclinum
Superciclin
Synotodecin
Transcycline
Bristacin
Solvocillin
Velacicline
Syntetrex
Prm-TC
Abricycline
Syntodecin
Tetraverin
Kinteto
Hostacyclin PRM
751-97-3
Pyrrolidino-methyl-tetracycline
Synterin (TN)
Pirrolidinometil-tetraciclina
N-(Pyrrolidinomethyl)tetracycline
AC1NQZM8
pyrrolidinylmethyltetracycline
Pyrolidinomethyltetracycline
N-(1-Pyrrolidinylmethyl)-tetracycline
UNII-GH9IW85221
Rolitetracyclinum [INN-Latin]
AAT 4
Rolitetraciclina [INN-Spanish]
Tetracycline, pyrrolidinomethyl-
ROLITETRACYCLINE [MI]
CHEBI:63334
n-Pyrrolidino-methyl-tetracycline
ROLITETRACYCLINE [INN]
ROLITETRACYCLINE [JAN]
SCHEMBL155640
HMEYVGGHISAPJR-IAHYZSEUSA-N
ROLITETRACYCLINE [USAN]
AC1O711S
C27H33N3O8
GH9IW85221
Rolitetracycline (Technical Grade)
SQ 15,659
CHEMBL1237046
DTXSID7023568
NSC-759177
ROLITETRACYCLINE [MART.]
SCHEMBL21831095
CTK8G2985
EINECS 212-031-9
GTPL12760
ROLITETRACYCLINE [WHO-DD]
IKQRPFTXKQQLJF-IAHYZSEUSA-N
HMS2094O15
Pharmakon1600-01505684
Rolitetracycline (JAN/USAN/INN)
SQ 15
SQ-15659
BCP15881
NSC50352
Pirrolidinometil-tetraciclina [Italian]
Rolitetracycline, analytical standard
BDBM50477463
EBC-27279
MFCD00864995
N-(1-Pyrrolidinylmethyl)tetracycline
NSC759177
ZINC14880004
N-(pyrrolidin-1-ylmethyl)tetracycline
AKOS024284365
C27-H33-N3-O8
Tetracycline, N-(pyrrolidinylmethyl)-
AR29566
CCG-213512
CID5282179
DB01301
J4.526H
NSC 759177
Rolitetracycline [USAN:BAN:INN:JAN]
Rolitetracycline [USAN:INN:BAN:JAN]
Rolitetracycline [USAN:USP:INN:BAN:JAN]
NCGC00263906-01
HY-18257
PD132300
SO-15659
SQ 15659
ST075203
SBI-0206901.P001
SO 15,659
CS-0007350
X5947
D02282
G12690
AB01563105_01
AB01563105_02
EN300-19651952
SR-05000001744
Q3940320
SR-05000001744-1
(4S,4aS,5aS,6S,12aR)-4-(dimethylamino)-1,6,10,11,12a-pentahydroxy-6-methyl-3,12-dioxo-N-(pyrrolidin-1-ylmethyl)-4,4a,5,5a-tetrahydrotetracene-2-carboxamide
(4S,4aS,5aS,6S,12aS)-4-(dimethylamino)-3,6,10,12,12a-pentahydroxy-6-methyl-1,11-dioxo-N-[(pyrrolidin-1-yl)methyl]-1,4,4a,5,5a,6,11,12a-octahydrotetracene-2-carboxamide
4-(Dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,6,10,12,12a-pentahydroxy-6-methyl-1,11-dioxo-N-(1-pyrrolidinylmethyl)-2-naphthacenecarboxamide
(4S,4aS,5aS,6S,12aS)-4-(dimethylamino)-3,6,10,12,12a-pentahydroxy-6-methyl-1,11-dioxo-N-(pyrrolidin-1-ylmethyl)-1,4,4a,5,5a,6,11,12a-octahydrotetracene-2-carboxamide
(4S,4aS,5aS,6S,12aS)-4-(dimethylamino)-3,6,10,12,12a-pentahydroxy-6-methyl-1,11-dioxo-N-(pyrrolidin-1-ylmethyl)-4,4a,5,5a-tetrahydrotetracene-2-carboxamide
[(4S,6S,12aS,4aS,5aS)-4-(dimethylamino)-3,6,10,12,12a-pentahydroxy-6-methyl-1, 11-dioxo(4,5,6,12a,4a,5a-hexahydronaphthacen-2-yl)]-N-(pyrrolidinylmethyl)carb oxamide
2-Naphthacenecarboxamide, 4-(dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,6,10,12,12a-pentahydroxy-6-methyl-1,11-dioxo-N-(1-pyrrolidinylmethyl)-, (4S-(4alpha,4aalpha,5aalpha,6beta,12aalpha))-
68060-64-0
(2E,4S,4aS,5aS,6S,12aS)-4-(dimethylamino)-6,10,11,12a-tetrahydroxy-2-[hydroxy-(pyrrolidin-1-ylmethylamino)methylidene]-6-methyl-4,4a,5,5a-tetrahydrotetracene-1,3,12-trione
(2S)-2-HYDROXY-3-METHYL-N-[(2S)-1-{[(1S)-3-METHYL-2-OXO-2,3,4,5-TETRAHYDRO-1H-3-BENZAZEPIN-1-YL]AMINO}-1-OXOPROPAN-2-YL]BUTANAMIDE
(2Z,4S,4aS,5aS,6S,12aS)-4-(dimethylamino)-6,10,11,12a-tetrahydroxy-2-[hydroxy-(pyrrolidin-1-ylmethylamino)methylidene]-6-methyl-4,4a,5,5a-tetrahydrotetracene-1,3,12-trione
(4S)-4-(Dimethylamino)-1,4,4abeta,5,5abeta,6,11,12a-octahydro-3,6alpha,10,12,12abeta-pentahydroxy-6beta-methyl-1,11-dioxo-N-(1-pyrrolidinylmethyl)-2-naphthacenecarboxamide
(4S)-4beta-(Dimethylamino)-1,4,4abeta,5,5abeta,6,11,12a-octahydro-3,6alpha,10,12,12abeta-pentahydroxy-6-methyl-1,11-dioxo-N-(1-pyrrolidinylmethyl)-2-naphthacenecarboxamide
(4S,4aS,5aS,6S,12aS)-4-(Dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,6,10,12,12a-pentahydroxy-6-methyl-1,11-dioxo-N-(1-pyrrolidinylmethyl)-2-naphthacenecarboxamide
2-Naphthacenecarboxamide, 4-(dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,6,10,12,12a-pentahydroxy-6-methyl-1,11-dioxo-N-(1-pyrrolidinylmethyl)-, (4S,4aS,5aS,6S,12aS)-; 2-Naphthacenecarboxamide, 4-(dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,6,10,12,12a-pentahydroxy-6-methyl-1,11-dioxo-N-(1-pyrrolidinylmethyl)- (6CI,8CI); 2-Naphthacenecarboxamide, 4-(dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,6,10,12,12a-pentahydroxy-6-methyl-1,11-dioxo-N-(1-pyrrolidinylmethyl)-, [4S-(4a,4aa,5aa,6ss,12aa)]-; 4-(Dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,6,10,12,12a-pentahydroxy-6-methyl-1,11-dioxo-N-(1-pyrrolidinylmethyl)-2-naphthacenecarboxamide; Abricycline; Bristacin; N-(1-Pyrrolidinylmethyl)tetracycline; N-(Pyrrolidinomethyl)tetracycline; Pyrrolidinylmethyltetracycline; Reverin; Rolitetracycline; SQ 15659; Superciclin; Synotodecin; Syntetrin; Tetraverin; Transcycline; Velacycline
2-NAPHTHACENECARBOXAMIDE, 4-(DIMETHYLAMINO)-1,4,4A,5,5A,6,11,12A-OCTAHYDRO-3,6,10,12,12A-PENTAHYDROXY-6-METHYL-1,11-DIOXO-N-(1-PYRROLIDINYLMETHYL)-, (4S-(4.ALPHA.,4A.ALPHA.,5A.ALPHA.,6.BETA.,12A.ALPHA))
2-Naphthacenecarboxamide, 4-(dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,6,10,12,12a-pentahydroxy-6-methyl-1,11-dioxo-N-(1-pyrrolidinylmethyl)-, [4S-(4.alpha.,4a.alpha.,5a.alpha.,6.beta.,12a.alpha.)]-